米国の緑内障および網膜治療装置市場：2007年

Abstract

The glaucoma and retinal device market was valued at over $100 million in 2005.

Research Methodology

The following report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.

Secondary sources include:

Government Sources:

• Securities and Exchange Commission filings
• Food and Drug Administration and patent filings
• National Center for Health Statistics data

Ophthalmic Device Companies:

• Annual reports, product brochures, corporate profiles, etc.

Internal Databases and Reports:

• Previous reports on similar/related sources

General Internet Searches, Medical Literature and Newspaper/Magazine Searches:

• Identifying various centers of specialization and articles that might provide leads for primary research.

The secondary research stage builds the foundation for the primary research. The primary research methodology has four steps:

Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is, thus, either discarded or marked as high or low priority. It is then organized appropriately as determined by the structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the implications of the information for the various ophthalmic segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes units and US$ and market shares).

Step 3: At this stage, the research is in position for its most important primary phase- expert interviews. Throughout the secondary research, industry and medical experts are identified. These experts are now contacted by telephone and asked to participate in interviews on recent trends and developments in the industry. Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of the particular interviewee, although in most cases, the most important questions are asked of all experts. The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then either augmented, discarded, or adjusted, based on the views and positions put forth. Attempts are made, whenever possible, to cross-check the views of various experts against each other and reach positions of consensus on issues and market numbers.

Step 4: The final stage of primary research involves individual and group analysis by Millennium Research Group. All research results are assessed and cross-checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 MARKET OVERVIEW

• 1.1 Market Overview
• 1.2 Market Analysis
  • 1.2.1 Procedures
  • 1.2.2 Market Forecast
    • 1.2.2.1 Ophthalmic Lasers
    • 1.2.2.2 Vitrectomy Consoles and Kits
    • 1.2.2.3 Glaucoma Drainage Devices
    • 1.2.2.4 Endoscopic Cyclophotocoagulation
    • 1.2.2.5 Emerging Technologies
  • 1.2.3 Market Drivers and Limiters
    • 1.2.3.1 Market Drivers
    • 1.2.3.2 Market Limiters
• 1.3 Competitive Analysis

2.0 GLAUCOMA AND RETINAL PROCEDURE OVERVIEW

• 2.1 Procedure Overview
• 2.2 Procedure Analysis
  • 2.2.1 Retinal Procedures
    • 2.2.1.1 Photocoagulation
    • 2.2.1.2 Vitrectomy
    • 2.2.1.3 Photodynamic Therapy
  • 2.2.2 Glaucoma Procedures
    • 2.2.2.1 Laser Trabeculoplasty
    • 2.2.2.2 Trabeculectomy
    • 2.2.2.3 Glaucoma Drainage Device Implantation
    • 2.2.2.4 Cyclophotocoagulation
    • 2.2.2.5 Other Procedures
    • 2.2.2.6 Emerging Procedures

3.0 OPHTHALMIC LASER MARKET

• 3.1 Market Overview
• 3.2 Market Analysis
  • 3.2.1 Photocoagulation Laser Market Forecast
    • 3.2.1.1 532 nm Wavelength Laser Market
    • 3.2.1.2 Multiwavelength Laser Market
    • 3.2.1.3 810 nm Laser Market
  • 3.2.2 SLT Laser Market Forecast
  • 3.2.3 Photodynamic Laser Market Forecast
  • 3.2.4 Market Drivers and Limiters
    • 3.2.4.1 Market Drivers
    • 3.2.4.2 Market Limiters
• 3.3 Competitive Analysis
  • 3.3.1 Emerging Competitors

4.0 VITRECTOMY CONSOLE AND KIT MARKET

• 4.1 Market Overview
• 4.2 Market Analysis
  • 4.2.1 Market Forecast
    • 4.2.1.1 Vitrectomy Console Market Forecast
    • 4.2.1.2 Vitrectomy Kit Market Forecast
  • 4.2.2 Market Drivers and Limiters
    • 4.2.2.1 Market Drivers
    • 4.2.2.2 Market Limiters
• 4.3 Competitive Analysis

5.0 GLAUCOMA DRAINAGE DEVICE MARKETS

• 5.1 Market Overview
• 5.2 Market Analysis
  • 5.2.1 Market Forecast
    • 5.2.1.1 Standard Glaucoma Shunt Market Forecast
    • 5.2.1.2 Glaucoma Mini-Shunt Market Forecast
  • 5.2.2 Market Drivers and Limiters
    • 5.2.2.1 Market Drivers
    • 5.2.2.2 Market Limiters
• 5.3 Competitive Analysis
  • 5.3.1 Current Competitors
  • 5.3.2 Emerging Competitors

6.0 ENDOSCOPIC CYCLOPHOTOCOAGULATION MARKET

• 6.1 Market Overview
• 6.2 Market Analysis
  • 6.2.1 Market Forecast
  • 6.2.2 Market Drivers and Limiters
    • 6.2.2.1 Market Drivers
    • 6.2.2.2 Market Limiters
• 6.3 Competitive Analysis

7.0 EMERGING TECHNOLOGIES

• 7.1 Emerging Technologies for Glaucoma Treatment
  • 7.1.1 Canaloplasty
  • 7.1.2 Pneumatic Trabeculectomy
• 7.2 Emerging Technologies for Retinal Condition Treatment
  • 7.2.1 Rheopheresis
  • 7.2.2 Implantable Miniature Telescope

MRG ACRONYMS AND INITIALISMS

List of Exhibits

EXECUTIVE SUMMARY

• Exhibit ES-1: Glaucoma and Retinal Device Market, US (US$), 2004- 2010
• Exhibit ES-2: Glaucoma and Retinal Device Market, Single-Use Devices and Capital Equipment, US (US$), 2004- 2010
• Exhibit ES-3: Glaucoma and Retinal Procedure Volumes, US (US$), 2004- 2010
• Exhibit ES-4: Ophthalmic Laser Market, by Type, US (US$), 2004- 2010
• Exhibit ES-5: Vitrectomy Console and Kit Market, As a % of Total, US (US$), 2004- 2010
• Exhibit ES-6: Glaucoma Drainage Device Market, US (US$), 2004- 2010
• Exhibit ES-7: ECP Market, US (US$), 2004- 2010
• Exhibit ES-8: Leading Competitors in the Ophthalmic Device Market, US, 2005

CHAPTER 1: MARKET OVERVIEW

• Exhibit 1-1: Glaucoma and Retinal Device Market, US (US$), 2004- 2010
• Exhibit 1-2: Glaucoma and Retinal Device Market, Capital Equipment and Single-Use Devices, US (US$), 2004- 2010 (Tabular Format)
• Exhibit 1-3: Glaucoma and Retinal Device Market, Capital Equipment and Single-Use Devices, US (US$), 2004- 2010 (Graphical Format)
• Exhibit 1-4: Glaucoma and Retinal Device Market, by Device, US (US$), 2004- 2010 (Tabular Format)
• Exhibit 1-5: Glaucoma and Retinal Device Market, by Device, US (US$), 2004- 2010 (Graphical Format)
• Exhibit 1-6: Drivers and Limiters of the US Ophthalmic Device Market
• Exhibit 1-7: Leading Competitors in the Ophthalmic Device Market, by Device, US, 2005
• Exhibit 1-8: Leading Competitors in the Ophthalmic Device Market, US, 2004 (Graphical Format)

CHAPTER 2: OPHTHALMIC PROCEDURE OVERVIEW

• Exhibit 2-1: Glaucoma and Retinal Procedure Volumes, US, 2004- 2010
• Exhibit 2-2: Glaucoma and Retinal Procedure Volumes, by Type, US, 2004- 2010 (Tabular Format)
• Exhibit 2-3: Glaucoma and Retinal Procedure Volumes, by Type, US, 2004- 2010 (Graphical Format)
• Exhibit 2-4: Types of Retinal Disorders
• Exhibit 2-5: Retinal Procedure Volumes, US, 2004- 2010 (Tabular Format)
• Exhibit 2-6: Retinal Procedure Volumes, US, 2004- 2010 (Graphical Format)
• Exhibit 2-7: Retinal Procedure Volumes, by Procedure Type, 2004- 2010
• Exhibit 2-8: Retinal Procedure Volumes, by Procedure Type, as a % of Total, US, 2004- 2010
• Exhibit 2-9: Types of Glaucoma
• Exhibit 2-10: Glaucoma Procedure Volumes, US, 2004- 2010 (Tabular Format)
• Exhibit 2-11: Glaucoma Procedure Volumes, US, 2004- 2010 (Graphical Format)

CHAPTER 3: OPHTHALMIC LASER MARKET

• Exhibit 3-1: Ophthalmic Laser Market, US (US$), 2004- 2010
• Exhibit 3-2: Ophthalmic Laser Market, by Type, US (US$), 2004- 2010 (Tabular Format)
• Exhibit 3-3: Ophthalmic Laser Market, by Type, US (US$), 2004- 2010 (Graphical Format)
• Exhibit 3-4: Ophthalmic Laser Units, by Type, US, 2004- 2010 (Tabular Format)
• Exhibit 3-5: Ophthalmic Laser Units, by Type, US, 2004- 2010 (Graphical Format)
• Exhibit 3-6: Photocoagulation Laser Market, US (US$), 2004- 2010 (Tabular Format)
• Exhibit 3-7: Photocoagulation Laser Market, US (US$), 2004- 2010 (Graphical Format)
• Exhibit 3-8: Photocoagulation Laser Market, by Type, US (US$), 2004- 2010 (Tabular Format)
• Exhibit 3-9: Photocoagulation Laser Market, by Type, US (US$), 2004- 2010 (Graphical Format)
• Exhibit 3-10: Photocoagulation Laser Units, by Type, US, 2004- 2010 (Tabular Format)
• Exhibit 3-11: Photocoagulation Laser Units, by Type, US, 2004- 2010 (Graphical Format)
• Exhibit 3-12: 532 nm Photocoagulation Laser Market, US (US$), 2004- 2010 (Tabular Format)
• Exhibit 3-13: 532 nm Photocoagulation Laser Market, US (US$), 2004- 2010 (Graphical Format)
• Exhibit 3-14: Multiwavelength Photocoagulation Laser Market, US (US$), 2004- (Tabular Format)
• Exhibit 3-15: Multiwavelength Photocoagulation Laser Market, US (US$), 2004- (Graphical Format)
• Exhibit 3-16: 810 nm Photocoagulation Laser Market, US (US$), 2004- 2010 (Tabular Format)
• Exhibit 3-17: 810 nm Photocoagulation Laser Market, US (US$), 2004- 2010 (Graphical Format)
• Exhibit 3-18: SLT Laser Market, US (US$), 2004- 2010 (Tabular Format)
• Exhibit 3-19: SLT Laser Market, US (US$), 2004- 2010 (Graphical Format)
• Exhibit 3-20: Photodynamic Laser Market, US (US$), 2004- 2010 (Tabular Format)
• Exhibit 3-21: Photodynamic Laser Market, US (US$), 2004- 2010 (Graphical Format)
• Exhibit 3-22: Drivers and Limiters of the Ophthalmic Laser Market, US
• Exhibit 3-23: Leading Competitors in the Ophthalmic Laser Market, by Segment, 2005
• Exhibit 3-24: Leading Competitors in the Ophthalmic Laser Market, US, 2005

CHAPTER 4: VITRECTOMY CONSOLE AND KIT MARKET

• Exhibit 4-1: Vitrectomy Market, US (US$), 2004- 2010
• Exhibit 4-2: Vitrectomy Market, by Type, US (US$), 2004- 2010 (Tabular Format)
• Exhibit 4-3: Vitrectomy Market, by Type, US (US$), 2004- 2010 (Graphical Format)
• Exhibit 4-4: Vitrectomy Console Market, US (US$), 2004- 2010 (Tabular Format)
• Exhibit 4-5: Vitrectomy Console Market, US (US$), 2004- 2010 (Graphical Format)
• Exhibit 4-6: Vitrectomy Kit Market, US (US$), 2004- 2010 (Tabular Format)
• Exhibit 4-7: Vitrectomy Kit Market, US (US$), 2004- 2010 (Graphical Format)
• Exhibit 4-8: Drivers and Limiters of the Vitrectomy Console Market, US
• Exhibit 4-9: Leading Competitors in the Vitrectomy Console and Kit Market, by Segment, US, 2005
• Exhibit 4-10: Leading Competitors in the Vitrectomy Console and Kit Market, US, 2005

CHAPTER 5: GLAUCOMA DRAINAGE DEVICE MARKET

• Exhibit 5-1: Glaucoma Drainage Device Market, US (US$), 2004- 2010 (Graphical Format)
• Exhibit 5-2: Glaucoma Drainage Device Market, US (US$), 2004- 2010
• Exhibit 5-3: Glaucoma Drainage Device Market, by Type, US (US$), 2004- 2010
• Exhibit 5-4: Glaucoma Drainage Device Market, by Type, as a % of Total, US, 2004- 2010
• Exhibit 5-5: Glaucoma Drainage Devices Units, by Type, US, 2004- 2010
• Exhibit 5-6: Glaucoma Drainage Devices Units, by Type, US, 2004- 2010
• Exhibit 5-7: Standard Glaucoma Shunt Market, US (US$), 2004- 2010 (Tabular Format)
• Exhibit 5-8: Standard Glaucoma Shunt Market, US (US$), 2004- 2010 (Graphical Format)
• Exhibit 5-9: Glaucoma Mini-Shunt Market, US (US$), 2004- 2010 (Tabular Format)
• Exhibit 5-10: Glaucoma Mini-Shunt Market, US (US$), 2004- 2010 (Graphical Format)
• Exhibit 5-11: Drivers and Limiters of the Glaucoma Drainage Device Market, US
• Exhibit 5-12: Leading Competitors in the Glaucoma Drainage Device Market, by Segment, US, 2005
• Exhibit 5-13: Leading Competitors in the Glaucoma Drainage Device Market, US, 2005

CHAPTER 6: ENDOSCOPIC CYCLOPHOTOCOAGULATION MARKET

• Exhibit 6-1: ECP Market, US (US$), 2004- 2010 (Graphical Format)
• Exhibit 6-2: ECP Market, US (US$), 2004- 2010 (Tabular Format)
• Exhibit 6-3: Drivers and Limiters of the ECP Market, US
• Exhibit 6-4: Leading Competitors in the ECP Market, US, 2005

CHAPTER 7: EMERGING TECHNOLOGIES

• Exhibit 7-1: Emerging Technologies in the Glaucoma Market, US, 2005
• Exhibit 7-2: Emerging Technologies in the Retinal Market, US, 2005
• Exhibit 7-3: The Penetration of Rheopheresis into the Stage 3 and 4 Dry AMD Market, US, 2005